Schrödinger, Inc.
Senior Computational Chemist, Target Druggability and Structure-Based Design
Be an Early Applicant
Support drug discovery projects through computational chemistry and modeling, target druggability assessment, structure-based design, virtual screening, and identification of alternative conformations or cryptic binding pockets. Collaborate with structural biology, medicinal chemistry, biochemistry, biology, and software engineering teams; integrate structural, computational, biophysical, and biological evidence; propose experiments and calculations; improve drug discovery technologies; and share expertise across the Therapeutics Group.
Schrödinger seeks a Senior Scientist in Computational Chemistry (Target Druggability and Structure-Based Drug Design) to join us in our mission to transform the discovery of therapeutics!
As a member of the Schrödinger Therapeutics Group (STG), you’ll join a team of over 60 scientists that includes designers, modelers, computational chemists, medicinal chemists, crystallographers, biochemists, and biologists with experience working on all common target classes and therapeutic areas. The group is supported by more than 100 software developers and engineers, as well as a large-scale computer infrastructure.
Who will love this job:
- A structure-based drug designer with deep training in molecular modelling, with an emphasis on the following areas: structural biology, computationally-driven lead optimization, virtual ligand screening, generative structure prediction, or cryptic pocket identification.
- A scientist trained cross-functionally, with experience in both computational chemistry and experimental structural biology or experimental hit-finding environments
- A team player who enjoys working in interdisciplinary environments and has excellent communication skills
What you’ll do:
- Support active drug discovery projects as a computational chemist/modeler
- Contribute to new-target selection by integrating structural, computational, biophysical, and biological evidence into concise target-tractability assessments, identifying key uncertainties and proposing experiments or calculations that could resolve them.
- Partner with cross-functional experts to develop strategies for promising targets, including approaches to investigate alternative conformations or potential transient binding sites.
- Work closely with the internal software development teams to improve Schrödinger’s drug discovery technologies.
- Share knowledge with the greater Schrödinger Therapeutic Group (STG)
What you should have:
- PhD in Computational Chemistry, Structural Biology, or a related discipline
- Experience in structure-based drug design and the ability to critically interpret protein structures in the context of ligand binding, drawing on modern computational and experimental approaches for structure prediction and cryptic pocket identification
- Postdoctoral experience and/or at least one year of industry experience preferred
Pay and perks:
Schrödinger understands it’s people that make a company great. Because of this, we’re prepared to offer a competitive salary, equity-based compensation, and a wide range of benefits that include healthcare (with dental and vision), a 401k, pre-tax commuter benefits, a flexible work schedule, and a parental leave program. We have a company culture that is relaxed, but engaged, and over a month of paid vacation time. Our Office Management team also plans a myriad of fun company-wide events. New York is home to our largest office, but we have teams all over the world. Schrödinger is honored to have been included in Crain's New York Best Places to Work, BuiltIn's NYC Best Place to Work, and Newsweek's list of America's 100 Most Loved Workplaces.
Estimated base salary range: $100,000 - $1800,000. Actual compensation package is dependent on a number of factors, including, for example, experience, education, degrees held, market data, and business needs. If you have any questions regarding the compensation for this role, do not hesitate to reach out to a member of our Strategic Growth team.
Sound exciting? Apply today and join us!
As an equal opportunity employer, Schrödinger hires outstanding individuals into every position in the company. People who work with us have a high degree of engagement, a commitment to working effectively in teams, and a passion for the company's mission. We place the highest value on creating a safe environment where our employees can grow and contribute, and refuse to discriminate on the basis of race, color, religious belief, sex, age, disability, national origin, alienage or citizenship status, marital status, partnership status, caregiver status, sexual and reproductive health decisions, gender identity or expression, sexual orientation, or any other protected characteristic. To us, "diversity" isn't just a buzzword, but an important element of our core principles and key business practices. We believe that diverse companies innovate better and think more creatively than homogenous ones because they take into account a wide range of viewpoints. For us, greater diversity doesn't mean better headlines or public images - it means increased adaptability and profitability.
Similar Jobs at Schrödinger, Inc.
Healthtech • Machine Learning • Software • Biotech • Pharmaceutical
Provide computational chemistry and molecular modeling support for drug discovery projects, develop modeling approaches, troubleshoot computational issues, share expertise, and collaborate with software developers to improve therapeutic discovery technologies. The role focuses on structure-based drug design, lead optimization, molecular dynamics, free-energy methods, virtual screening, cheminformatics, and ADMET modeling.
Top Skills:
Admet ModelingChemically-Aware DatabasesCheminformaticsCoding And ScriptingFree-Energy MethodsMachine LearningMolecular DynamicsVirtual Ligand Screening
Healthtech • Machine Learning • Software • Biotech • Pharmaceutical
Leads enterprise application projects and serves as the technical authority for NetSuite and related business systems. Responsibilities include configuration, customization, integrations, workflow improvements, troubleshooting production issues, data-quality initiatives, technical standards, deployments, documentation, user training, and mentoring. Partners with technical and business teams to deliver scalable solutions across a polyglot cloud environment.
Top Skills:
.NetAWSC#CoupaGCPGitJavaScriptNetSuitePHPSalesforceSQLSuitescript 1.0Suitescript 2.XTypescriptWeb Services
Healthtech • Machine Learning • Software • Biotech • Pharmaceutical
Develop and drive DMPK and PK/PD strategies for drug discovery projects. Represent DMPK on cross-functional teams, collaborate with CROs, analyze ADME and physicochemical data, support multiparameter optimization, author regulatory reports, interact with agencies, and help establish predictive computational ADME/DMPK models.
Top Skills:
AdmeDmpkMatlab SimbiologyMonolixPbpkPhoenix/WinnonlinPk/PdSimcyp
What you need to know about the San Francisco Tech Scene
San Francisco and the surrounding Bay Area attracts more startup funding than any other region in the world. Home to Stanford University and UC Berkeley, leading VC firms and several of the world’s most valuable companies, the Bay Area is the place to go for anyone looking to make it big in the tech industry. That said, San Francisco has a lot to offer beyond technology thanks to a thriving art and music scene, excellent food and a short drive to several of the country’s most beautiful recreational areas.
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine
